Detalhe da pesquisa
1.
Impact of early cyclosporine A levels on acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation using in vivo T-cell depletion.
Cytotherapy
; 26(5): 490-497, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385908
2.
Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma.
Am J Hematol
; 99(5): 1008-1011, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38425185
3.
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMT.
Am J Hematol
; 98(11): 1685-1698, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37548390
4.
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.
Am J Hematol
; 98(5): 770-783, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36814396
5.
Multistep pathogenesis of chronic myelomonocytic leukemia in patients.
Eur J Haematol
; 109(1): 50-57, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35299281
6.
PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms.
Am J Hematol
; 97(4): 390-400, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35015307
7.
Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia.
Eur J Haematol
; 107(2): 265-274, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33998054
8.
Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic Leukemia.
Int J Mol Sci
; 21(17)2020 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32842710
9.
Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients.
Int J Mol Sci
; 21(8)2020 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32344757
10.
CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation.
Br J Haematol
; 184(4): 625-633, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30198568
11.
Time-dependent changes in mortality and transformation risk in MDS.
Blood
; 128(7): 902-10, 2016 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27335276
12.
Intensive consolidation with G-CSF support: Tolerability, safety, reduced hospitalization, and efficacy in acute myeloid leukemia patients ≥60 years.
Am J Hematol
; 92(10): E567-E574, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28699225
13.
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.
Int J Mol Sci
; 18(2)2017 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28212292
14.
New data shed light on Y-loss-related pathogenesis in myelodysplastic syndromes.
Genes Chromosomes Cancer
; 54(12): 717-24, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26394808
15.
Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis.
Ann Hematol
; 93(1): 57-64, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24241126
16.
Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.
Ann Hematol
; 93(11): 1825-38, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24951123
17.
TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancer.
J Cancer Res Clin Oncol
; 149(10): 7113-7123, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36877279
18.
Impact of the Recipient's Pre-Treatment Blood Lymphocyte Count on Intended and Unintended Effects of Anti-T-Lymphocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation.
Cells
; 12(14)2023 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37508496
19.
Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options-A Single-Center Experience.
Cancers (Basel)
; 15(24)2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38136284
20.
Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients-A Retrospective Single-Center Analysis.
Vaccines (Basel)
; 11(10)2023 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37896938